{"id":18472,"date":"2022-11-25T12:54:13","date_gmt":"2022-11-25T12:54:13","guid":{"rendered":"https:\/\/clinlabint.com\/?p=18472"},"modified":"2022-11-25T12:54:13","modified_gmt":"2022-11-25T12:54:13","slug":"integra-biosciences-submits-science-based-emissions-reduction-targets-to-join-the-sbti","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/integra-biosciences-submits-science-based-emissions-reduction-targets-to-join-the-sbti\/","title":{"rendered":"INTEGRA Biosciences submits science-based emissions reduction targets to join the SBTi"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

INTEGRA Biosciences submits science-based emissions reduction targets to join the SBTi<\/h1>\/ in E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

INTEGRA Biosciences is proud to announce that it has submitted company-wide emissions reduction targets through the Science Based Targets initiative (SBTi), with the aim of limiting global warming to 1.5 \u00b0C and achieving net zero by 2050 at the latest.<\/h3>\n

<\/p>\n

The SBTi partnership independently assesses and approves companies\u2019 targets in line with strict criteria, helping to define and support best practices for ambitious climate action in the private sector. To join this initiative, INTEGRA has published a report summarizing the carbon footprint of its production sites and sales offices, and publicly committed to the following emissions reduction targets:<\/p>\n